CHINA PHARMA HOLDINGS, INC. Proceeds from Notes Payable
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Proceeds from Notes Payable of $0 for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-20.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2014-03-20
- CHINA PHARMA HOLDINGS, INC. proceeds from notes payable for the quarter ending 2011-12-31 was $0.00, a 100.00% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. proceeds from notes payable for the quarter ending 2010-12-31 was $753.90K.
- CHINA PHARMA HOLDINGS, INC. proceeds from notes payable for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- CHINA PHARMA HOLDINGS, INC. proceeds from notes payable for fiscal 2012 was $793.22K.
- CHINA PHARMA HOLDINGS, INC. proceeds from notes payable for fiscal 2011 was $0.00, a 100.00% decline from fiscal 2010.
- CHINA PHARMA HOLDINGS, INC. proceeds from notes payable for fiscal 2010 was $3.69M.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|
| 2013-12-31 | $0.00 10-K · filed 2014-03-20 | ||
| 2012-12-31 | $793.22K 10-K · filed 2014-03-20 | ||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-14 | $0.00 10-K · filed 2013-03-14 | |
| 2011-09-30 | $0.00 10-Q/A · filed 2012-03-06 | ||
| 2010-12-31 | $753.90K derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-14 | $3.69M 10-K · filed 2012-03-14 | |
| 2010-09-30 | $2.93M 10-Q/A · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |